12 Health Care Stocks Moving In Wednesday's Intraday Session
Portfolio Pulse from Benzinga Insights
Healthcare stocks experienced significant movements in Wednesday's intraday session. INVO Bioscience led the gainers with a 275% increase following its Q4 earnings report, while Dare Bioscience topped the losers, dropping 40.7%. Other notable movers included Vanda Pharma, Galera Therapeutics, and SINTX Techs on the gainers' side, and Longeveron, Sage Therapeutics, and China SXT Pharmaceuticals among the losers.
April 17, 2024 | 4:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Dare Bioscience shares fell 40.7% to $0.29, with a market value of $28.9 million.
Dare Bioscience's significant drop in stock price could be due to negative news, disappointing earnings, or other factors that have adversely affected investor confidence.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
INVO Bioscience stock surged 275% to $2.85, with a market value of $7.4 million after its Q4 earnings report.
The significant surge in INVO Bioscience's stock price is directly attributed to its Q4 earnings report, indicating strong performance or positive future outlook that has positively influenced investor sentiment.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Vanda Pharma stock increased by 33.33% to $5.4, with a market cap of $310.7 million.
Vanda Pharma's stock price increase suggests positive investor sentiment, possibly due to favorable company news, strong performance, or sector trends.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90